Related Experiment Videos
Complement activation in nephropathia epidemica caused by Puumala hantavirus
A Paakkala1, J Mustonen, M Viander
1Medical School, University of Tampere, Finland.
Clinical Nephrology
|July 6, 2000
Summary
Complement activation is common in Nephropathia epidemica (NE), a Puumala hantavirus infection. Classical pathway activation is linked to severe NE, indicating its role in disease severity.
Area of Science:
- Immunology
- Virology
- Nephrology
Background:
- Nephropathia epidemica (NE) is a hemorrhagic fever with renal syndrome caused by Puumala hantavirus.
- Clinical severity of NE varies significantly, with pathogenesis and complement activation data being limited.
- Understanding complement system behavior in NE is crucial for explaining clinical outcome variations.
Purpose of the Study:
- To investigate complement system activation during NE.
- To determine if complement activation correlates with the clinical severity of NE.
Main Methods:
- Studied complement component levels and activation products in 25 hospitalized, acutely ill NE patients.
- Monitored the clinical course of NE patients.
- Assessed complement activation pathways (classical, alternative, or both) and levels of soluble terminal complex SC5b-9 and C4d/C4 ratio.
Main Results:
- Complement activation was detected in 23 out of 25 NE patients.
- The classical complement pathway activation was associated with a more severe clinical course.
- Elevated soluble terminal complex SC5b-9 was the most sensitive indicator of complement activation.
Conclusions:
- Complement activation is a frequent occurrence in NE.
- Activation of the classical complement pathway, potentially by immune complexes or viral components, correlates with severe NE clinical presentation.